KR102625196B1 - Lactic acid bacteria nutritional composition for companion animals with excellent palatability - Google Patents
Lactic acid bacteria nutritional composition for companion animals with excellent palatability Download PDFInfo
- Publication number
- KR102625196B1 KR102625196B1 KR1020230051597A KR20230051597A KR102625196B1 KR 102625196 B1 KR102625196 B1 KR 102625196B1 KR 1020230051597 A KR1020230051597 A KR 1020230051597A KR 20230051597 A KR20230051597 A KR 20230051597A KR 102625196 B1 KR102625196 B1 KR 102625196B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- lactobacillus
- lactic acid
- nutritional composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 124
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 94
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 68
- 239000004310 lactic acid Substances 0.000 title claims abstract description 47
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 47
- 241001465754 Metazoa Species 0.000 title claims abstract description 40
- 241000894006 Bacteria Species 0.000 title claims abstract description 33
- 235000019629 palatability Nutrition 0.000 title claims abstract description 25
- 239000000843 powder Substances 0.000 claims abstract description 49
- 206010010774 Constipation Diseases 0.000 claims abstract description 21
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000008280 blood Substances 0.000 claims abstract description 19
- 210000004369 blood Anatomy 0.000 claims abstract description 19
- 230000001580 bacterial effect Effects 0.000 claims abstract description 17
- 235000021028 berry Nutrition 0.000 claims abstract description 17
- 102000004190 Enzymes Human genes 0.000 claims abstract description 15
- 108090000790 Enzymes Proteins 0.000 claims abstract description 15
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 15
- 238000000855 fermentation Methods 0.000 claims abstract description 15
- 230000004151 fermentation Effects 0.000 claims abstract description 15
- 239000003112 inhibitor Substances 0.000 claims abstract description 14
- 235000007542 Cichorium intybus Nutrition 0.000 claims abstract description 13
- 229930003231 vitamin Natural products 0.000 claims abstract description 11
- 235000013343 vitamin Nutrition 0.000 claims abstract description 11
- 239000011782 vitamin Substances 0.000 claims abstract description 11
- 229940088594 vitamin Drugs 0.000 claims abstract description 11
- 241000241413 Propolis Species 0.000 claims abstract description 10
- 229940069949 propolis Drugs 0.000 claims abstract description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 10
- 239000011787 zinc oxide Substances 0.000 claims abstract description 10
- 244000000626 Daucus carota Species 0.000 claims abstract description 8
- 235000002767 Daucus carota Nutrition 0.000 claims abstract description 8
- 244000017020 Ipomoea batatas Species 0.000 claims abstract description 8
- 235000002678 Ipomoea batatas Nutrition 0.000 claims abstract description 8
- 235000013351 cheese Nutrition 0.000 claims abstract description 8
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims abstract description 8
- 244000298479 Cichorium intybus Species 0.000 claims abstract 2
- 235000013339 cereals Nutrition 0.000 claims description 23
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 10
- 239000008103 glucose Substances 0.000 claims description 10
- 229920001542 oligosaccharide Polymers 0.000 claims description 9
- 239000003755 preservative agent Substances 0.000 claims description 9
- 230000002335 preservative effect Effects 0.000 claims description 9
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 8
- 244000062793 Sorghum vulgare Species 0.000 claims description 8
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 8
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 8
- 239000000905 isomalt Substances 0.000 claims description 8
- 235000010439 isomalt Nutrition 0.000 claims description 8
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 8
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 7
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 7
- 235000010469 Glycine max Nutrition 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 6
- 241000186660 Lactobacillus Species 0.000 claims description 6
- 229920002774 Maltodextrin Polymers 0.000 claims description 6
- 239000005913 Maltodextrin Substances 0.000 claims description 6
- 229940039696 lactobacillus Drugs 0.000 claims description 6
- 229940035034 maltodextrin Drugs 0.000 claims description 6
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 6
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 claims description 5
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 5
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 5
- 240000001717 Vaccinium macrocarpon Species 0.000 claims description 5
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 claims description 5
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 5
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 5
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 5
- GGTYBZJRPHEQDG-WCCKRBBISA-N (2s)-2,5-diaminopentanoic acid hydrochloride Chemical compound Cl.NCCC[C@H](N)C(O)=O GGTYBZJRPHEQDG-WCCKRBBISA-N 0.000 claims description 4
- 235000009328 Amaranthus caudatus Nutrition 0.000 claims description 4
- 240000001592 Amaranthus caudatus Species 0.000 claims description 4
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 4
- 241000186012 Bifidobacterium breve Species 0.000 claims description 4
- 241001608472 Bifidobacterium longum Species 0.000 claims description 4
- 235000003351 Brassica cretica Nutrition 0.000 claims description 4
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims description 4
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims description 4
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims description 4
- 235000003343 Brassica rupestris Nutrition 0.000 claims description 4
- 241001107116 Castanospermum australe Species 0.000 claims description 4
- 241000371652 Curvularia clavata Species 0.000 claims description 4
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 4
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 4
- 244000199866 Lactobacillus casei Species 0.000 claims description 4
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 4
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 4
- 241000186606 Lactobacillus gasseri Species 0.000 claims description 4
- 240000002605 Lactobacillus helveticus Species 0.000 claims description 4
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims description 4
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 4
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 4
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 4
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 4
- 241000186869 Lactobacillus salivarius Species 0.000 claims description 4
- 240000004371 Panax ginseng Species 0.000 claims description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 4
- 235000004347 Perilla Nutrition 0.000 claims description 4
- 244000124853 Perilla frutescens Species 0.000 claims description 4
- 241000405414 Rehmannia Species 0.000 claims description 4
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 4
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 4
- 244000057717 Streptococcus lactis Species 0.000 claims description 4
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 4
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 4
- 244000269722 Thea sinensis Species 0.000 claims description 4
- 235000021307 Triticum Nutrition 0.000 claims description 4
- 244000098338 Triticum aestivum Species 0.000 claims description 4
- 235000011453 Vigna umbellata Nutrition 0.000 claims description 4
- 240000001417 Vigna umbellata Species 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 235000012735 amaranth Nutrition 0.000 claims description 4
- 239000004178 amaranth Substances 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 4
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 4
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims description 4
- 235000021279 black bean Nutrition 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 4
- 235000008434 ginseng Nutrition 0.000 claims description 4
- 235000009569 green tea Nutrition 0.000 claims description 4
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 4
- 229940017800 lactobacillus casei Drugs 0.000 claims description 4
- 229940012969 lactobacillus fermentum Drugs 0.000 claims description 4
- 229940054346 lactobacillus helveticus Drugs 0.000 claims description 4
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 4
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 4
- 235000019713 millet Nutrition 0.000 claims description 4
- 235000010460 mustard Nutrition 0.000 claims description 4
- 229960003244 ornithine hydrochloride Drugs 0.000 claims description 4
- 235000002020 sage Nutrition 0.000 claims description 4
- 244000061520 Angelica archangelica Species 0.000 claims description 3
- 241001444063 Aronia Species 0.000 claims description 3
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 3
- 240000005250 Chrysanthemum indicum Species 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 3
- 241000218231 Moraceae Species 0.000 claims description 3
- 235000008708 Morus alba Nutrition 0.000 claims description 3
- 240000007651 Rubus glaucus Species 0.000 claims description 3
- 235000021019 cranberries Nutrition 0.000 claims description 3
- 235000015872 dietary supplement Nutrition 0.000 claims description 3
- 235000021013 raspberries Nutrition 0.000 claims description 3
- 241000238424 Crustacea Species 0.000 claims description 2
- 241000186000 Bifidobacterium Species 0.000 claims 1
- 244000056139 Brassica cretica Species 0.000 claims 1
- 244000018436 Coriandrum sativum Species 0.000 claims 1
- 235000002787 Coriandrum sativum Nutrition 0.000 claims 1
- 241000218587 Lactobacillus paracasei subsp. paracasei Species 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 17
- 230000009286 beneficial effect Effects 0.000 abstract description 9
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 abstract description 6
- 230000007413 intestinal health Effects 0.000 abstract description 6
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 abstract description 5
- 210000000936 intestine Anatomy 0.000 abstract description 5
- 229960003104 ornithine Drugs 0.000 abstract description 5
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 abstract description 4
- 238000004321 preservation Methods 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 33
- 230000036541 health Effects 0.000 description 14
- 241000723343 Cichorium Species 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 9
- 235000013305 food Nutrition 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 235000014692 zinc oxide Nutrition 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 6
- 235000021329 brown rice Nutrition 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 241000282472 Canis lupus familiaris Species 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 240000000851 Vaccinium corymbosum Species 0.000 description 4
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 4
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 235000021014 blueberries Nutrition 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- 235000011888 snacks Nutrition 0.000 description 4
- 241000219198 Brassica Species 0.000 description 3
- 241000209205 Coix Species 0.000 description 3
- 244000077995 Coix lacryma jobi Species 0.000 description 3
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 3
- 240000008620 Fagopyrum esculentum Species 0.000 description 3
- 240000005979 Hordeum vulgare Species 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- 241000186605 Lactobacillus paracasei Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 240000004731 Acer pseudoplatanus Species 0.000 description 2
- 235000002754 Acer pseudoplatanus Nutrition 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 239000001692 EU approved anti-caking agent Substances 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 235000006485 Platanus occidentalis Nutrition 0.000 description 2
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 2
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 235000003650 acai Nutrition 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 235000004634 cranberry Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000020774 essential nutrients Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- SUVMJBTUFCVSAD-UHFFFAOYSA-N sulforaphane Chemical compound CS(=O)CCCCN=C=S SUVMJBTUFCVSAD-UHFFFAOYSA-N 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- SUVMJBTUFCVSAD-JTQLQIEISA-N 4-Methylsulfinylbutyl isothiocyanate Natural products C[S@](=O)CCCCN=C=S SUVMJBTUFCVSAD-JTQLQIEISA-N 0.000 description 1
- 240000004246 Agave americana Species 0.000 description 1
- 235000018865 Angelica gigas Nutrition 0.000 description 1
- 240000001810 Angelica gigas Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000289659 Erinaceidae Species 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000287530 Psittaciformes Species 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 230000037231 joint health Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960005559 sulforaphane Drugs 0.000 description 1
- 235000015487 sulforaphane Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
- A23K10/22—Animal feeding-stuffs from material of animal origin from fish
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/704—Vitamin B
- A23V2250/7042—Vitamin B1
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/704—Vitamin B
- A23V2250/7052—Vitamin B6
Abstract
본 발명은 기호도가 우수한 반려동물용 유산균 영양제 조성물에 관한 것으로, 더욱 상세하게는 당성분, 유산균 혼합물, 산화아연, 비타민 혼합물, 프로폴리스, 곡물발효 효소, 오메가-3, 치커리 추출물, 오르니틴염삼염, 고구마 분말, 당근 분말, 보로콜리 분말, 베리류 혼합물, 혈당상승 억제제, 치즈 분말 및 고결방지제로 이루어진다.
상기의 성분으로 이루어지는 기호도가 우수한 반려동물용 유산균 영양제 조성물은 반려동물의 장에 유익한 성분으로 이루어져 장건강, 모질 및 변비를 개선하며, 우수한 기호도와 보존성을 나타낸다.The present invention relates to a lactic acid bacteria nutritional composition for pets with excellent palatability, and more specifically, to a lactic acid bacteria nutritional composition for companion animals, including sugar ingredients, lactic acid bacteria mixture, zinc oxide, vitamin mixture, propolis, grain fermentation enzyme, omega-3, chicory extract, ornithine trisalt, It consists of sweet potato powder, carrot powder, boroccoli powder, berry mixture, blood sugar inhibitor, cheese powder, and anti-caking agent.
The lactic acid bacterial nutritional composition for pets with excellent palatability consisting of the above ingredients consists of ingredients beneficial to the intestines of companion animals, improves intestinal health, coat quality, and constipation, and exhibits excellent palatability and preservation.
Description
본 발명은 기호도가 우수한 반려동물용 유산균 영양제 조성물에 관한 것으로, 더욱 상세하게는 반려동물의 장에 유익한 성분으로 이루어져 장건강, 모질 및 변비를 개선하며, 우수한 기호도와 보존성을 나타내는 반려동물용 유산균 영양제 조성물에 관한 것이다.The present invention relates to a lactic acid bacterial nutritional composition for companion animals with excellent palatability, and more specifically, to a lactic acid bacterial nutritional composition for companion animals that consists of ingredients beneficial to the intestinal tract of companion animals, improves intestinal health, coat quality, and constipation, and exhibits excellent palatability and preservation properties. It relates to composition.
종래에는 사람과 같이 생활하는 개나 고양이 등의 동물을 사람에게 즐거움을 주기 위해 기르는 동물이라는 뜻으로 '애완동물'이라 칭하였으나, 최근에는 동물이 사람과 함께 더불어 살아가며 심리적으로 안정감과 친밀감을 주는 친구나 가족과 같은 존재라는 뜻에서 '반려동물'이라 부르고 있다.Previously, animals such as dogs and cats that live with people were called 'pets' to mean animals raised to give people pleasure, but recently, animals live with people and are used as friends or companions who provide psychological stability and intimacy. They are called ‘companion animals’ because they are like family members.
반려동물은 전통적인 반려동물인 개와 고양이뿐만 아니라 앵무새, 고슴도치, 토끼 및 햄스터 등으로 그 종류가 다양해지고 있는데, 최근에는 반려동물에 대한 애정의 표현 정도가 높아지고, 반려동물을 보살피기 위한 관련 산업이 각광을 받고 있다.The types of companion animals are becoming more diverse, including not only traditional pets such as dogs and cats, but also parrots, hedgehogs, rabbits, and hamsters. Recently, the level of expression of affection for companion animals has increased, and related industries to care for companion animals have been in the spotlight. I'm receiving it.
이에 반려동물의 사료나 간식과 관련한 산업은 반려동물의 건강과 직결된 산업에 해당하기 때문에 더욱 관심이 집중되는 분야이고, 반려동물의 사료나 간식도 사람이 섭취하는 음식과 비슷한 종류의 것까지 접근해 있는 추세이며, 반려동물의 사료나 간식이 될 수 있는 비스켓, 껌, 육포 또는 음료 등은 반려동물의 건강에 유익할 뿐만 아니라 스트레스도 줄여줄 수 있기 때문에 사람의 음식과 더욱 유사한 종류로 확장되고 있다.Accordingly, the industry related to pet food or snacks is a field that is receiving more attention because it is an industry directly related to the health of pets, and pet food and snacks are also approached to similar types of food consumed by humans. There is a growing trend, and biscuits, gum, jerky, or drinks that can be used as pet food or snacks are expanding into types that are more similar to human food because they are not only beneficial to the health of pets but can also reduce stress. there is.
또한, 최근에는 반려동물의 사료나 간식이 단순히 영양 성분을 공급하기 위한 수단에서 벗어나, 각종 기능성 성분을 함유하여, 반려동물의 건강을 증진시킬 뿐만 아니라 기호도에 맞게 식감이나 향 등이 개선된 제품에 대한 소비자의 요구가 증가하고 있다.In addition, in recent years, pet food and snacks have moved beyond simply being a means of supplying nutrients, and have now become products that contain various functional ingredients that not only improve the health of pets, but also have improved texture and flavor to suit their preferences. Consumer demand is increasing.
또한, 영양공급이나 질병관리가 확대되어 반려동물의 수명이 점차 향상되고 있는데, 반려동물의 수명 향상으로 인한 장관련 질환의 발생과, 섭취하는 음식의 변화와 실내에서 주로 생활하는 환경으로 인한 운동부족 및 스트레스로 인해 변비증상을 앓는 반려동물의 수가 증가하고 있는 문제점이 있었다.In addition, the lifespan of companion animals is gradually improving due to the expansion of nutritional supply and disease management, and the occurrence of intestinal diseases due to the improvement in the lifespan of companion animals, changes in the food consumed, and lack of exercise due to living environments mainly indoors. There was a problem that the number of pets suffering from constipation symptoms due to stress was increasing.
본 발명의 목적은 반려동물의 장에 유익한 성분으로 이루어져 장건강, 모질 및 변비를 개선하며, 우수한 기호도와 보존성을 나타내는 기호도가 우수한 반려동물용 유산균 영양제 조성물을 제공하는 것이다.The purpose of the present invention is to provide a lactic acid nutrient composition for companion animals with excellent palatability, which consists of ingredients beneficial to the intestines of companion animals, improves intestinal health, coat quality, and constipation, and exhibits excellent palatability and preservation properties.
본 발명의 목적은 당성분, 유산균 혼합물, 산화아연, 비타민 혼합물, 프로폴리스, 곡물발효 효소, 오메가-3, 치커리 추출물, 오르니틴염삼염, 고구마 분말, 당근 분말, 보로콜리 분말, 베리류 혼합물, 혈당상승 억제제, 치즈 분말 및 고결방지제로 이루어지는 것을 특징으로 하는 기호도가 우수한 반려동물용 유산균 영양제 조성물을 제공함에 의해 달성된다.The purpose of the present invention is to treat sugar ingredients, lactic acid bacteria mixture, zinc oxide, vitamin mixture, propolis, grain fermentation enzyme, omega-3, chicory extract, ornithine trisalt, sweet potato powder, carrot powder, boroccoli powder, berry mixture, and increase in blood sugar level. This is achieved by providing a lactic acid bacteria nutritional composition for companion animals with excellent palatability, which is characterized by comprising an inhibitor, cheese powder, and an anti-caking agent.
본 발명의 바람직한 특징에 따르면, 상기 기호도가 우수한 반려동물용 유산균 영양제 조성물은 당성분 100 중량부, 유산균 혼합물 0.5 내지 1 중량부, 산화아연 0.5 내지 0.7 중량부, 비타민 혼합물 0.02 내지 0.04 중량부, 프로폴리스 0.2 내지 0.3 중량부, 곡물발효 효소 0.5 내지 0.6 중량부, 오메가-3 0.1 내지 0.3 중량부, 치커리 추출물 0.5 내지 1 중량부, 오르니틴염산염 0.1 내지 0.3 중량부, 고구마 분말 1 내지 2 중량부, 당근 분말 1 내지 2 중량부, 브로콜리 분말 1 내지 2 중량부, 베리류 혼합물 2 내지 4 중량부, 혈당상승 억제제 8 내지 12 중량부, 치즈 분말 4 내지 5 중량부 및 고결방지제 20 내지 30 중량부로 이루어지는 것으로 한다.According to a preferred feature of the present invention, the lactic acid bacteria nutritional composition for pets with excellent palatability contains 100 parts by weight of sugar component, 0.5 to 1 part by weight of lactic acid bacteria mixture, 0.5 to 0.7 parts by weight of zinc oxide, 0.02 to 0.04 parts by weight of vitamin mixture, and pro 0.2 to 0.3 parts by weight of polys, 0.5 to 0.6 parts by weight of grain fermentation enzyme, 0.1 to 0.3 parts by weight of omega-3, 0.5 to 1 part by weight of chicory extract, 0.1 to 0.3 parts by weight of ornithine hydrochloride, 1 to 2 parts by weight of sweet potato powder, It consists of 1 to 2 parts by weight of carrot powder, 1 to 2 parts by weight of broccoli powder, 2 to 4 parts by weight of berry mixture, 8 to 12 parts by weight of a blood sugar rise inhibitor, 4 to 5 parts by weight of cheese powder, and 20 to 30 parts by weight of an anti-caking agent. do.
본 발명의 더 바람직한 특징에 따르면, 상기 당성분은 무수결정포도당, 프락토올리고당, 이소말트, 갈락토올리고당, 말토올리고당, 자일로올리고당 및 겐티오올리고당으로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것으로 한다.According to a more preferred feature of the present invention, the sugar component is composed of one or more selected from the group consisting of anhydrous crystalline glucose, fructooligosaccharide, isomalt, galactooligosaccharide, maltooligosaccharide, xylooligosaccharide, and gentiooligosaccharide.
본 발명의 더욱 바람직한 특징에 따르면, 상기 유산균 혼합물은 락토코커스 락티스(Lactococcus lactis), 락토바실러스 플란타룸(Lactobacillus plantarum), 스트렙토코쿠스 써모필루스(Streptococcus thermophilus), 락토바실러스 아시도필루스(Lactobacillus acidophilus), 비피도박터리움 비피덤(Bifidobacterium bifidum), 락토바실러스 람노서스(Lactobacillus rhamnosus), 락토바실러스 루테리(Lactobacillus reuteri), 비피도박터리움 롱검(Bifidobacterium longum), 락토바실러스 헬베티쿠스(Lactobacillus helveticus), 락토바실러스 파라카제이(Lactobacillus paracasei), 비피도박터리움 아니말리스 ssp. 락티스(Bifidobacterium animalis ssp. lactis), 비피도박터리움 브레베(Bifidobacterium breve), 락토바실러스 살리바리스(Lactobacillus salivarius), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus), 락토바실러스 카제이(Lactobacillus casei), 락토바실러스 가쎄리(Lactobacillus gasseri) 및 락토바실러스 퍼멘툼(Lactobacillus fermentum)으로 이루어지는 것으로 한다.According to a more preferred feature of the present invention, the lactic acid bacteria mixture includes Lactococcus lactis, Lactobacillus plantarum , Streptococcus thermophilus , and Lactobacillus acidophilus ( Lactobacillus acidophilus , Bifidobacterium bifidum , Lactobacillus rhamnosus , Lactobacillus reuteri , Bifidobacterium longum , Lactobacillus helveticus ), Lactobacillus paracasei , Bifidobacterium animalis ssp. Lactis ( Bifidobacterium animalis ssp. lactis ), Bifidobacterium breve , Lactobacillus salivarius, Lactobacillus bulgaricus , Lactobacillus casei , Lactobacillus It is made of Lactobacillus gasseri and Lactobacillus fermentum .
본 발명의 더욱 더 바람직한 특징에 따르면, 상기 비타민 혼합물은 비타민 B1 및 비타민 B6로 이루어지는 것으로 한다.According to an even more preferred feature of the present invention, the vitamin mixture is composed of vitamin B 1 and vitamin B 6 .
본 발명의 더욱 더 바람직한 특징에 따르면, 상기 곡물발효 효소는 곡물 100 중량부에 황국균 0.1 내지 0.3 중량부를 접종한 후에 30 내지 40℃의 온도에서 20 내지 25시간 동안 발효하여 제조되며, 상기 곡물은 현미, 현미율무, 보리, 대두, 흑미, 수수, 옥수수, 통밀, 율무씨앗, 기장씨앗, 검정콩, 차조, 팥, 서목태, 메밀 및 아마란스로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것으로 한다.According to an even more preferred feature of the present invention, the grain fermentation enzyme is produced by inoculating 0.1 to 0.3 parts by weight of Chrysanthemum fungus in 100 parts by weight of grain and then fermenting at a temperature of 30 to 40° C. for 20 to 25 hours, and the grain is brown rice. , brown rice coix, barley, soybeans, black rice, sorghum, corn, whole wheat, coix seeds, millet seeds, black beans, perilla, red beans, blackcurrant, buckwheat and amaranth.
본 발명의 더욱 더 바람직한 특징에 따르면, 상기 베리류 혼합물은 블루베리, 크랜베리, 라즈베리, 아사이베리, 아로니아, 오디 및 복분자로 이루어진 그룹에서 선택된 하나 이상의 분말로 이루어지는 것으로 한다.According to an even more preferred feature of the present invention, the berry mixture is composed of one or more powders selected from the group consisting of blueberries, cranberries, raspberries, acai berries, aronia, mulberries, and bokbunja.
본 발명의 더욱 더 바람직한 특징에 따르면, 상기 혈당상승 억제제는 난소화성말토덱스트린으로 이루어지는 것으로 한다.According to an even more preferred feature of the present invention, the blood glucose rise inhibitor is made of indigestible maltodextrin.
본 발명의 더욱 더 바람직한 특징에 따르면, 상기 고결방지제는 결정 셀룰로오스로 이루어지는 것으로 한다.According to an even more preferred feature of the present invention, the anti-caking agent is made of crystalline cellulose.
본 발명의 더욱 더 바람직한 특징에 따르면, 상기 기호도가 우수한 반려동물용 유산균 영양제 조성물에는 상기 당성분 100 중량부 대비 천연보존제 0.01 내지 0.1 중량부가 더 함유되며, 상기 천연보존제는 녹차, 머스타드, 로즈마리 및 세이지로 이루어진 그룹에서 선택된 하나의 동결건조 분말인 것으로 한다.According to an even more preferred feature of the present invention, the lactic acid bacterial nutritional composition for pets with excellent preference further contains 0.01 to 0.1 parts by weight of a natural preservative based on 100 parts by weight of the sugar component, and the natural preservative is green tea, mustard, rosemary and sage. It is assumed to be a freeze-dried powder selected from the group consisting of.
본 발명의 더욱 더 바람직한 특징에 따르면, 상기 기호도가 우수한 반려동물용 유산균 영양제 조성물에는 상기 당성분 100 중량부 대비 변비개선용 조성물 0.1 내지 0.5 중량부가 더 함유되며, 상기 변비개선용 조성물은 생지황, 사삼, 치커리, 지각, 우슬 및 당귀로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것으로 한다.According to an even more preferred feature of the present invention, the lactic acid bacterial nutritional composition for pets with excellent preference further contains 0.1 to 0.5 parts by weight of a composition for improving constipation relative to 100 parts by weight of the sugar component, and the composition for improving constipation includes raw rehmannia root and ginseng. , it shall be composed of one or more selected from the group consisting of chicory, crustacean, sycamore and angelica root.
본 발명에 따른 기호도가 우수한 반려동물용 유산균 영양제 조성물은 반려동물의 장에 유익한 성분으로 이루어져 장건강, 모질 및 변비를 개선하며, 우수한 기호도와 보존성을 나타내는 영양제 조성물을 제공하는 탁월한 효과를 나타낸다.The lactic acid bacterial nutritional composition for companion animals with excellent palatability according to the present invention consists of ingredients beneficial to the intestinal tract of companion animals, improves intestinal health, coat quality, and constipation, and has the excellent effect of providing a nutritional composition with excellent palatability and preservability.
이하에는, 본 발명의 바람직한 실시예와 각 성분의 물성을 상세하게 설명하되, 이는 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 발명을 용이하게 실시할 수 있을 정도로 상세하게 설명하기 위한 것이지, 이로 인해 본 발명의 기술적인 사상 및 범주가 한정되는 것을 의미하지는 않는다.Below, preferred embodiments of the present invention and the physical properties of each component are described in detail, but are intended to be described in detail so that those skilled in the art can easily practice the invention. This does not mean that the technical idea and scope of the present invention are limited.
본 발명에 따른 기호도가 우수한 반려동물용 유산균 영양제 조성물은 당성분, 유산균 혼합물, 산화아연, 비타민 혼합물, 프로폴리스, 곡물발효 효소, 오메가-3, 치커리 추출물, 오르니틴염삼염, 고구마 분말, 당근 분말, 보로콜리 분말, 베리류 혼합물, 혈당상승 억제제, 치즈 분말 및 고결방지제로 이루어지며, 당성분 100 중량부, 유산균 혼합물 0.5 내지 1 중량부, 산화아연 0.5 내지 0.7 중량부, 비타민 혼합물 0.02 내지 0.04 중량부, 프로폴리스 0.2 내지 0.3 중량부, 곡물발효 효소 0.5 내지 0.6 중량부, 오메가-3 0.1 내지 0.3 중량부, 치커리 추출물 0.5 내지 1 중량부, 오르니틴염산염 0.1 내지 0.3 중량부, 고구마 분말 1 내지 2 중량부, 당근 분말 1 내지 2 중량부, 브로콜리 분말 1 내지 2 중량부, 베리류 혼합물 2 내지 4 중량부, 혈당상승 억제제 8 내지 12 중량부, 치즈 분말 4 내지 5 중량부 및 고결방지제 20 내지 30 중량부로 이루어지는 것이 바람직하다.The lactic acid bacterial nutritional composition for pets with excellent preference according to the present invention includes sugar ingredients, lactic acid bacteria mixture, zinc oxide, vitamin mixture, propolis, grain fermentation enzyme, omega-3, chicory extract, ornithine trisalt, sweet potato powder, carrot powder, It consists of boroccoli powder, berry mixture, blood sugar level inhibitor, cheese powder and anti-caking agent, 100 parts by weight of sugar component, 0.5 to 1 part by weight of lactic acid bacteria mixture, 0.5 to 0.7 part by weight of zinc oxide, 0.02 to 0.04 part by weight of vitamin mixture, 0.2 to 0.3 parts by weight of propolis, 0.5 to 0.6 parts by weight of grain fermentation enzyme, 0.1 to 0.3 parts by weight of omega-3, 0.5 to 1 part by weight of chicory extract, 0.1 to 0.3 parts by weight of ornithine hydrochloride, 1 to 2 parts by weight of sweet potato powder , 1 to 2 parts by weight of carrot powder, 1 to 2 parts by weight of broccoli powder, 2 to 4 parts by weight of berry mixture, 8 to 12 parts by weight of a blood sugar rise inhibitor, 4 to 5 parts by weight of cheese powder, and 20 to 30 parts by weight of an anti-caking agent. It is desirable.
상기 당성분은 본 발명에 따른 기호도가 우수한 반려동물용 유산균 영양제 조성물에 단맛을 부여하여 기호도를 향상 시키는 역할을 하는데, 무수결정포도당, 프락토올리고당, 이소말트, 갈락토올리고당, 말토올리고당, 자일로올리고당, 겐티오올리고당 및 아가베시럽으로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것이 바람직하며, 무수결정포도당 100 중량부에 프락토올리고당, 이소말트, 갈락토올리고당, 말토올리고당, 자일로올리고당 및 겐티오올리고당으로 이루어진 그룹에서 선택된 하나 이상의 올리고당 10 내지 12 중량부를 혼합하여 이루어지는 것이 더욱 바람직하다.The sugar component serves to improve palatability by imparting sweetness to the highly palatable lactic acid bacterial nutritional composition for pets according to the present invention, including anhydrous crystalline glucose, fructooligosaccharide, isomalt, galactooligosaccharide, maltooligosaccharide, and xylo. It is preferably composed of one or more selected from the group consisting of oligosaccharides, gentio-oligosaccharides and agave syrup, and is composed of fructooligosaccharides, isomalt, galactooligosaccharides, maltooligosaccharides, xylooligosaccharides and gentio-oligosaccharides per 100 parts by weight of anhydrous crystalline glucose. It is more preferable to mix 10 to 12 parts by weight of one or more oligosaccharides selected from the group consisting of.
상기 무수결정포도당은 단맛을 부가할 뿐만 아니라, 본 발명에 따른 영양제 조성물을 분말형태로의 제조하는 과정에서 분말화 공정의 효율성을 증진시키는 역할을 하며, 상기 프락토올리고당, 이소말트, 갈락토올리고당, 말토올리고당, 자일로올리고당 및 겐티오올리고당은 단맛을 부여하면서도 체내 흡수율이 낮은 성분으로 이루어져 반려 동물의 건강을 증진시키는 역할을 한다.The anhydrous crystalline glucose not only adds sweetness, but also plays a role in improving the efficiency of the powdering process in the process of manufacturing the nutritional composition according to the present invention in powder form, and the fructooligosaccharide, isomalt, and galactooligosaccharide , maltooligosaccharide, xylooligosaccharide, and gentio-oligosaccharide are composed of ingredients that impart sweetness but have a low absorption rate in the body, and play a role in improving the health of companion animals.
상기 무수결정포도당 100 중량부 대비 올리고당의 함량이 10 중량부 미만이면 영양제 조성물의 단맛과 기호도가 저하될 수 있으며, 올리고당의 함량이 12 중량부를 초과하게 되면 영양제 조성물의 분말화 공정의 효율성이 저하될 수 있다.If the content of oligosaccharides is less than 10 parts by weight compared to 100 parts by weight of anhydrous crystalline glucose, the sweetness and palatability of the nutritional composition may be reduced, and if the content of oligosaccharides exceeds 12 parts by weight, the efficiency of the powdering process of the nutritional composition may be reduced. You can.
상기 유산균 혼합물은 0.5 내지 1 중량부가 함유되며, 락토코커스 락티스(Lactococcus lactis), 락토바실러스 플란타룸(Lactobacillus plantarum), 스트렙토코쿠스 써모필루스(Streptococcus thermophilus), 락토바실러스 아시도필루스(Lactobacillus acidophilus), 비피도박터리움 비피덤(Bifidobacterium bifidum), 락토바실러스 람노서스(Lactobacillus rhamnosus), 락토바실러스 루테리(Lactobacillus reuteri), 비피도박터리움 롱검(Bifidobacterium longum), 락토바실러스 헬베티쿠스(Lactobacillus helveticus), 락토바실러스 파라카제이(Lactobacillus paracasei), 비피도박터리움 아니말리스 ssp. 락티스(Bifidobacterium animalis ssp. lactis), 비피도박터리움 브레베(Bifidobacterium breve), 락토바실러스 살리바리스(Lactobacillus salivarius), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus), 락토바실러스 카제이(Lactobacillus casei), 락토바실러스 가쎄리(Lactobacillus gasseri) 및 락토바실러스 퍼멘툼(Lactobacillus fermentum)으로 이루어지는 것이 바람직하다.The lactic acid bacteria mixture contains 0.5 to 1 part by weight of Lactococcus lactis, Lactobacillus plantarum , Streptococcus thermophilus , and Lactobacillus acidophilus. acidophilus ), Bifidobacterium bifidum, Lactobacillus rhamnosus , Lactobacillus reuteri , Bifidobacterium longum , Lactobacillus helveticus , Lactobacillus paracasei , Bifidobacterium animalis ssp. Lactis ( Bifidobacterium animalis ssp. lactis ), Bifidobacterium breve , Lactobacillus salivarius, Lactobacillus bulgaricus , Lactobacillus casei , Lactobacillus It is preferably made of Lactobacillus gasseri and Lactobacillus fermentum .
상기의 성분으로 이루어지는 유산균 혼합물은 반려동물의 장내에서 면역조절과 항균작용을 하는 유익균의 증식을 도우며, 장건강을 개선하여 설사나 변비의 개선 효과를 나타내는데, 상기 유산균 혼합물의 함량이 0.5 중량부 미만이면 상기의 효과가 미미하며, 상기 유산균 혼합물의 함량이 1 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 제조비용을 지나치게 증가시키고 영양제 조성물의 기호도를 저하시키기 때문에 바람직하지 못하다.The lactic acid bacteria mixture consisting of the above ingredients helps the growth of beneficial bacteria that regulate immunity and have antibacterial effects in the intestines of pets, and improves intestinal health, showing the effect of improving diarrhea or constipation. The content of the lactic acid bacteria mixture is less than 0.5 parts by weight. If so, the above effect is minimal, and if the content of the lactic acid bacteria mixture exceeds 1 part by weight, the above effect is not significantly improved, but the manufacturing cost is excessively increased and the preference of the nutritional composition is lowered, which is undesirable.
상기 산화아연은 0.5 내지 0.7 중량부가 함유되며, 산소와 아연의 화합물로 가벼운 백색 분말이며 아연화, 아연백이라고도 하는데, 천연에서는 홍아연석으로 존재하며 연소 및 가열 등을 통해 제조되고, 본 발명에 따른 영양제 조성물에 면역력 향상 효과를 부여하는 역할을 한다.The zinc oxide contains 0.5 to 0.7 parts by weight, is a light white powder made of a compound of oxygen and zinc, and is also called zinc oxide or zinc white. It exists in nature as red zinc stone and is manufactured through combustion and heating, etc., and is a nutritional supplement according to the present invention. It serves to impart an immunity-enhancing effect to the composition.
상기 비타민 혼합물은 0.02 내지 0.04 중량부가 함유되며, 비타민 B1 및 비타민 B6로 이루어지는데, 비타민 B1 100 중량부 및 비타민 B6 70 내지 90 중량부가 혼합되어 이루어지는 것이 바람직하다.The vitamin mixture contains 0.02 to 0.04 parts by weight and consists of vitamin B 1 and vitamin B 6 , and is preferably a mixture of 100 parts by weight of vitamin B 1 and 70 to 90 parts by weight of vitamin B 6.
상기 비타민 B1은 에너지대사를 원활하게 하며, 신경과 근육활동에 관여하고 세포의 성장과 발달을 촉진하며, 상기 비타민 B6는 신진대사를 돕고, 피부나 생체조직의 성장촉진 및 지방간의 개선 등의 효과를 나타내어 반려동물의 근육건강을 증진시키고 털을 윤기있게 하는 효과를 나타낸다.Vitamin B 1 facilitates energy metabolism, participates in nerve and muscle activity, and promotes cell growth and development, and vitamin B6 helps metabolism, promotes the growth of skin and biological tissue, and improves fatty liver disease. It is effective in improving the muscle health of pets and making their fur shiny.
상기 프로폴리스는 0.2 내지 0.3 중량부가 함유되는데, 상기 프로폴리스는 꿀벌이 자신을 병원균과 외부의 적으로부터 보호하기 위해 식물체로부터 채취한 천연왁스성분으로 유기물과 미네랄(무기염류)이 다량 함유되어 있을 뿐만 아니라, 비타민, 아미노산, 지방, 유기산 및 플라보노이드(flavonoid) 성분이 함유되어 세포대사에 중요한 역할을 하며, 전체적으로 항염, 항산화 및 항균 효과를 나타내어 반려동물의 구강염증을 개선하고, 항산화 및 면역력 증강의 효과를 나타내는 영양제 조성물이 제공될 수 있도록 하는 역할을 한다.The propolis contains 0.2 to 0.3 parts by weight. The propolis is a natural wax component collected from plants by bees to protect themselves from pathogens and external enemies, and contains a large amount of organic matter and minerals (inorganic salts). In addition, it contains vitamins, amino acids, fats, organic acids, and flavonoids, which play an important role in cell metabolism, and have overall anti-inflammatory, antioxidant, and antibacterial effects, improving oral inflammation in pets and enhancing antioxidant and immune function. It serves to provide a nutritional composition representing.
상기 프로폴리스의 함량이 0.2 중량부 미만이면 상기의 효과가 미미하며, 상기 프로폴리스의 함량이 0.3 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 영양제 조성물의 제조비용을 지나치게 증가시키기 때문에 바람직하지 못하다.If the propolis content is less than 0.2 parts by weight, the effect is minimal, and if the propolis content exceeds 0.3 parts by weight, the effect is not significantly improved and the manufacturing cost of the nutritional composition is excessively increased, so it is preferable. can't do it
상기 곡물발효 효소는 0.5 내지 0.6 중량부가 함유되며, 곡물 100 중량부에 황국균 0.1 내지 0.3 중량부를 접종한 후에 30 내지 40℃의 온도에서 20 내지 25시간 동안 발효하여 제조되며, 상기 곡물은 현미, 현미율무, 보리, 대두, 흑미, 수수, 옥수수, 통밀, 율무씨앗, 기장씨앗, 검정콩, 차조, 팥, 서목태, 메밀 및 아마란스로 이루어진 그룹에서 선택된 하나 이상으로 이루어진다.The grain fermentation enzyme contains 0.5 to 0.6 parts by weight, and is manufactured by inoculating 0.1 to 0.3 parts by weight of Chrysanthemum fungus into 100 parts by weight of grain and then fermenting for 20 to 25 hours at a temperature of 30 to 40 ℃. The grain is brown rice, brown rice, It consists of one or more selected from the group consisting of coix, barley, soybean, black rice, sorghum, corn, whole wheat, coix seed, millet seed, black bean, perilla, red bean, soybean, buckwheat and amaranth.
상기의 과정 및 성분으로 제조되는 곡물발효 효소는 본 발명을 통해 제조되는 영양제 조성물에 다양한 영양성분이 함유되도록 할 뿐만 아니라, 곡물에 함유되어 있는 유효성분이 반려동물의 체내에 흡수되는 효과가 향상되어 사료만으로는 부족한 영양성분의 간접공급원으로 사용되어질 수 있고, 또한 필수 영양소를 모두 포함하고 있고, 필수 영양소가 반려동물의 체내에 흡수되는 효과가 우수하여 반려동물의 건강증진, 변비개선 및 다이어트 효과를 부여한다.The grain fermentation enzyme manufactured through the above process and ingredients not only ensures that the nutritional composition manufactured through the present invention contains various nutrients, but also improves the absorption effect of the active ingredients contained in the grain into the pet's body, thereby improving the absorption of the active ingredients contained in the grain into the pet's body. It can be used as an indirect source of nutrients that are lacking on its own, and it also contains all essential nutrients, and is excellent at absorbing essential nutrients into the pet's body, thereby improving the pet's health, improving constipation, and providing diet effects. .
상기 곡물발효 효소의 함량이 0.5 중량부 미만이면 상기의 효과가 미미하며, 상기 곡물발효 효소의 함량이 0.6 중량부를 초과하게 되면 제조되는 영양제 조성물의 기호도가 현저하게 저하될 수 있기 때문에 바람직하지 못하다.If the content of the grain fermentation enzyme is less than 0.5 parts by weight, the effect is minimal, and if the content of the grain fermentation enzyme exceeds 0.6 parts by weight, the palatability of the manufactured nutritional composition may be significantly reduced, which is not preferable.
상기 오메가-3는 0.1 내지 0.3 중량부가 함유되며, 체내에 꼭 필요한 불포화 지방산으로 염증을 낮추고, 세포막을 튼튼하게 하여 반려 동물의 기관지 건강을 개선하는 역할을 한다.The omega-3 contains 0.1 to 0.3 parts by weight, and is an unsaturated fatty acid essential to the body, which reduces inflammation and strengthens cell membranes to improve the bronchial health of companion animals.
이때, 오메가-3는 DHA와 EPA로 이루어지는데, DHA성분이 망막에 고농도로 존재하여 시각발달과 안구의 항염작용을 통해 반려 동물의 눈 건강도 개선하는 효과를 나타낼 수 있다.At this time, Omega-3 is composed of DHA and EPA, and DHA exists in high concentration in the retina, which can improve the eye health of companion animals through visual development and anti-inflammatory effects in the eye.
상기 치커리 추출물은 0.5 내지 1 중량부가 함유되며, 이눌린이 다량 함유되어 장내 유익균의 먹이가 되고, 상기 유산균 혼합물이 장내에서 증식하는데 도움을 줄 뿐만 아니라, 변비개선의 효과를 나타낸다.The chicory extract contains 0.5 to 1 part by weight, contains a large amount of inulin, serves as food for beneficial intestinal bacteria, and not only helps the lactic acid bacteria mixture proliferate in the intestine, but also has the effect of improving constipation.
상기 치커리 추출물의 함량이 0.5 중량부 미만이면 상기의 효과가 미미하며, 상기 치커리 추출물의 함량이 1 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 영양제 조성물의 기호도가 저하될 수 있기 때문에 바람직하지 못하다.If the content of the chicory extract is less than 0.5 parts by weight, the effect is minimal, and if the content of the chicory extract exceeds 1 part by weight, the effect is not significantly improved and the preference for the nutritional composition may be reduced. can't do it
상기 오르니틴염산염은 0.1 내지 0.3 중량부가 함유되며, 향미 증진제의 역할을 할 뿐만 아니라, 성장호르몬을 분비해 근육 합성을 촉진하고 기초대사를 향상시켜 비만을 개선할 뿐만 아니라, 간장장애를 개선하는 효과를 나타내는데, L-오르니틴이나 L-아스파트산염 형태를 나타내는 것을 사용하는 것이 바람직하다.The ornithine hydrochloride contains 0.1 to 0.3 parts by weight and not only acts as a flavor enhancer, but also secretes growth hormones to promote muscle synthesis and improves basal metabolism, which not only improves obesity but also has the effect of improving liver disorders. It is preferable to use the form L-ornithine or L-aspartate.
상기 고구마 분말은 1 내지 2 중량부가 함유되며, 각종 영양성분이 풍부하게 함유되어 있을 뿐만 아니라, 우수한 단맛을 부여하여 반려동물의 건강증진 및 기호도가 향상된 영양제 조성물이 제공될 수 있도록 하는 역할을 한다.The sweet potato powder contains 1 to 2 parts by weight, and is not only rich in various nutrients, but also provides excellent sweetness to provide a nutritional composition that improves the health and preference of pets.
상기 당근 분말은 1 내지 2 중량부가 함유되며, 비타민 A등과 같은 영양성분이 풍부하게 함유되어 있으며, 섬유질, 탄수화물, 당분 등이 함유되어 있어, 반려동물의 시력보호 및 눈건강 개선 등의 효과를 부여하는 역할을 한다.The carrot powder contains 1 to 2 parts by weight, is rich in nutrients such as vitamin A, and contains fiber, carbohydrates, sugar, etc., providing effects such as protecting the eyesight of pets and improving eye health. It plays a role.
상기 브로콜리 분말은 1 내지 2 중량부가 함유되며, 설포라판 성분이 함유되어 폐에 잔존하는 유해물질을 제거해줘 반려동물의 기관지 건강을 개선하며, 비타민 C와 베타카로틴 성분이 풍부하게 함유되어 항산화 및 세포 건강에 도음을 주고 면역력을 개선하는 효과를 나타낸다.The broccoli powder contains 1 to 2 parts by weight and contains sulforaphane, which improves the bronchial health of pets by removing harmful substances remaining in the lungs, and is rich in vitamin C and beta-carotene, which promotes antioxidant and cell health. It helps and has the effect of improving immunity.
상기 베리류 혼합물은 2 내지 4 중량부가 함유되며, 블루베리, 크랜베리, 라즈베리, 아사이베리, 아로니아, 오디 및 복분자로 이루어진 그룹에서 선택된 하나 이상의 분말로 이루어지는 것이 바람직한데, 블루베리 분말과 크랜베리 분말이 1:1의 중량부로 혼합되어 이루어지는 것이 더욱 바람직하다.The berry mixture contains 2 to 4 parts by weight, and is preferably composed of one or more powders selected from the group consisting of blueberries, cranberries, raspberries, acai berries, aronia, mulberries, and bokbunja, where the blueberry powder and cranberry powder are 1. It is more preferable that it is mixed in a weight ratio of :1.
상기의 성분으로 이루어지는 베리류 혼합물은 특유의 맛과 향으로 인해 영양제 조성물의 기호도를 향상시킬 뿐만 아니라, 베리류에 함유된 베타카로틴과 비타민 A 및 비타민 C등의 함량이 높아 눈건강을 개선할 뿐만 아니라, 우수한 항산화효과를 나타내는 영양제 조성물이 제공될 수 있도록 하는 역할을 한다.The berry mixture composed of the above ingredients not only improves the preference of nutritional compositions due to its unique taste and aroma, but also improves eye health due to the high content of beta-carotene, vitamin A, and vitamin C contained in berries. It serves to provide a nutritional composition that exhibits excellent antioxidant effects.
상기 베리류 혼합물의 함량이 2 중량부 미만이면 상기의 효과가 미미하며, 상기 베리류 혼합물의 함량이 4 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 베리류 특유의 신맛으로 인해 영양제 조성물의 기호도가 저하될 수 있기 때문에 바람직하지 못하다.If the content of the berry mixture is less than 2 parts by weight, the effect is minimal, and if the content of the berry mixture exceeds 4 parts by weight, the effect is not significantly improved and the preference of the nutritional composition decreases due to the unique sour taste of berries. This is undesirable because it may deteriorate.
상기 혈당상승 억제제는 8 내지 12 중량부가 함유되며, 난소화성말토덱스트린으로 이루어지는데, 본 발명에 따른 영양제 조성물에 혈당상승억제 효과를 부여하는 역할을 한다.The blood sugar rise inhibitor contains 8 to 12 parts by weight and is made of indigestible maltodextrin, and serves to impart a blood sugar rise inhibitory effect to the nutritional composition according to the present invention.
본 발명을 통해 제조되는 영양제 조성물은 당성분의 함량이 높기 때문에, 비교적 체내 흡수율이 낮은 무수결정포도당, 프락토올리고당, 이소말트, 갈락토올리고당, 말토올리고당, 자일로올리고당 및 겐티오올리고당 등으로 이루어진 당 성분을 사용한다고 하더라도 영양제 조성물을 섭취하는 반려 동물의 체내 혈당이 상승하게 되는데, 상기와 같이 난소화성말토덱스트린으로 이루어진 혈당상승억제제를 혼합하게 되면 반려 동물의 체내 혈당 상승을 억제할 수 있다.Since the nutritional composition prepared through the present invention has a high sugar content, it is composed of anhydrous crystalline glucose, fructooligosaccharide, isomalt, galactooligosaccharide, maltooligosaccharide, xylooligosaccharide and gentio-oligosaccharide, etc., which have a relatively low absorption rate in the body. Even if a sugar component is used, the blood sugar level in the body of a companion animal that consumes the nutritional composition increases. However, if a blood sugar level inhibitor consisting of indigestible maltodextrin is mixed as described above, the rise in blood sugar level in the body of the companion animal can be suppressed.
또한, 상기 혈당상승 억제제로 사용되는 난소화성말토덱스트린은 수용성 식이섬유로, 혈당 상승 억제 효과 외에도, 장내 유익균 증가의 정장작용 및 혈중 지질 저하의 효과를 나타내어 반려 동물의 건강을 증진시키는 역할을 한다.In addition, indigestible maltodextrin, which is used as an inhibitor of blood sugar levels, is a water-soluble dietary fiber that, in addition to the effect of suppressing blood sugar levels, plays a role in improving the health of companion animals by exhibiting the effect of increasing intestinal beneficial bacteria and lowering blood lipids.
상기 혈당상승 억제제의 함량이 8 중량부 미만이면 상기의 효과가 미미하며, 상기 혈당상승 억제제의 함량이 12 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 영양제 조성물의 기호도가 지나치게 저하될 수 있기 때문에 바람직하지 못하다.If the content of the blood sugar level inhibitor is less than 8 parts by weight, the effect is minimal, and if the content of the blood sugar level inhibitor exceeds 12 parts by weight, the effect is not significantly improved and the preference of the nutritional composition may be excessively reduced. It is not desirable because there are
상기 치즈 분말은 4 내지 5 중량부가 함유되며, 본 발명을 통해 제조되는 영양제 조성물에 고소한 맛을 부여하여 기호도를 향상시킬 뿐만 아니라, 칼슘과 같은 다양한 영양성분이 풍부하게 함유되어 반려 동물의 관절 건강 개선효과를 부여하는 역할을 한다.The cheese powder contains 4 to 5 parts by weight, and not only improves preference by giving a nutty taste to the nutritional composition prepared through the present invention, but is also rich in various nutrients such as calcium, thereby improving the joint health of companion animals. It plays a role in giving effect.
상기 고결방지제는 20 내지 30 중량부가 함유되며, 결정 셀룰로오스로 이루어지는데, 발명을 통해 제조되는 영양제 조성물에 식이섬유 등을 공급할 뿐만 아니라, 고결방지효과를 나타내어 본 발명에 따른 영양제 조성물이 오랜기간 굳지 않고 분말형태를 유지할 수 있도록 하여 보존성을 향상시키는 역할을 한다.The anti-caking agent contains 20 to 30 parts by weight and is made of crystalline cellulose. It not only supplies dietary fiber, etc. to the nutritional composition prepared through the invention, but also exhibits an anti-caking effect, preventing the nutritional composition according to the present invention from hardening for a long period of time. It plays a role in improving preservability by maintaining the powder form.
상기 고결방지제의 함량이 20 중량부 미만이면 영양제 조성물이 미량의 수분으로도 쉽게 뭉치는 현상이 발생할 수 있으며, 상기 고결방지제의 함량이 30 중량부를 초과하게 되면 영양제 조성물의 고결방지효과는 크게 향상되지 않으면서 영양제 조성물의 기호도를 저하시킬 수 있기 때문에 바람직하지 못하다.If the content of the anti-caking agent is less than 20 parts by weight, the nutritional composition may easily clump up even with a trace amount of moisture. If the content of the anti-caking agent exceeds 30 parts by weight, the anti-caking effect of the nutritional composition will not be significantly improved. This is undesirable because it may reduce the palatability of the nutritional composition.
또한, 본 발명에 따른 기호도가 우수한 반려동물용 유산균 영양제 조성물에는 상기 당성분 100 중량부 대비 천연보존제 0.01 내지 0.1 중량부가 더 함유될 수 도 있는데, 상기 천연보존제는 녹차, 머스타드, 로즈마리 및 세이지로 이루어진 그룹에서 선택된 하나의 동결건조 분말인 것이 바람직하며, 녹차 분말, 머스타드 분말, 로즈마리 분말 및 세이지 분말이 1:1:1:1의 중량부로 혼합되어 이루어지는 것이 더욱 바람직하다.In addition, the lactic acid bacterial nutritional composition for pets with excellent preference according to the present invention may further contain 0.01 to 0.1 parts by weight of a natural preservative based on 100 parts by weight of the sugar component, and the natural preservative is composed of green tea, mustard, rosemary, and sage. It is preferable that it is a freeze-dried powder selected from the group, and more preferably it is a mixture of green tea powder, mustard powder, rosemary powder, and sage powder in a weight ratio of 1:1:1:1.
상기와 같이 성분으로 이루어지는 천연보존제는 강력한 항산화, 항균 및 보존력을 나타내어 본 발명을 통해 제조되는 영양제 조성물에 항산화 효과를 부여할 뿐만 아니라, 영양제 조성물의 변질이나 세균의 증식을 억제하여 보존성을 월등하게 향상시키는 역할을 한다.Natural preservatives composed of the ingredients described above exhibit strong antioxidant, antibacterial, and preservative properties, which not only imparts an antioxidant effect to the nutritional composition manufactured through the present invention, but also significantly improves the preservability by suppressing deterioration of the nutritional composition or proliferation of bacteria. It plays a role.
상기 천연보존제의 함량이 0.01 중량부 미만이면 상기의 효과가 미미하며, 상기 천연보존제의 함량이 0.1 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 영양제 조성물의 기호도를 저하시키기 때문에 바람직하지 못하다.If the content of the natural preservative is less than 0.01 part by weight, the effect is minimal, and if the content of the natural preservative exceeds 0.1 part by weight, the effect is not significantly improved and the preference of the nutritional composition is lowered, which is not desirable. .
또한, 본 발명에 따른 기호도가 우수한 반려동물용 유산균 영양제 조성물에는 상기 당성분 100 중량부 대비 변비개선용 조성물 0.1 내지 0.5 중량부가 더 함유될 수도 있는데, 상기 변비개선용 조성물은 생지황, 사삼, 치커리, 지각, 우슬 및 당귀로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것이 바람직하며, 생지황 100 중량부, 사삼 80 내지 120 중량부, 치커리 80 내지 120 중량부, 지각 30 내지 50 중량부, 우슬 30 내지 50 중량부 및 당귀 30 내지 50 중량부로 이루어지는 것이 더욱 바람직하다.In addition, the lactic acid bacterial nutritional composition for companion animals with excellent preference according to the present invention may further contain 0.1 to 0.5 parts by weight of a composition for improving constipation relative to 100 parts by weight of the sugar component, and the composition for improving constipation includes raw rehmannia root, ginseng, chicory, It is preferably composed of one or more selected from the group consisting of crust, sycamore and angelica root, 100 parts by weight of fresh rehmannia root, 80 to 120 parts by weight of ginseng, 80 to 120 parts by weight of chicory, 30 to 50 parts by weight of crust, and 30 to 50 parts by weight of cypress. And it is more preferable that it consists of 30 to 50 parts by weight of Angelica gigas.
상기의 성분으로 이루어지는 변비개선용 조성물은 식이섬유가 풍부하게 함유되어 반려동물의 변비개선 효과를 나타내며, 특유의 향으로 인해 반려동물의 스트레스를 개선하여 변비를 근본적으로 억제하는 효과를 나타낸다.The composition for improving constipation consisting of the above ingredients is rich in dietary fiber and has the effect of improving constipation in pets, and has the effect of fundamentally suppressing constipation by improving stress in pets due to its unique scent.
상기 변비개선용 조성물의 함량이 0.1 중량부 미만이면 상기의 효과가 미미하며, 상기 변비개선용 조성물의 함량이 0.5 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 변비개선용 조성물에서 발생하는 향이 강해져 영양제 조성물의 기호도가 저하될 수 있기 때문에 바람직하지 못하다.If the content of the composition for improving constipation is less than 0.1 part by weight, the above effect is minimal, and if the content of the composition for improving constipation exceeds 0.5 part by weight, the effect is not significantly improved and the effects generated from the composition for improving constipation are not significantly improved. This is undesirable because the flavor may become strong and the preference of the nutritional composition may decrease.
이하에서는, 본 발명에 따른 기호도가 우수한 반려동물용 유산균 영양제 조성물의 제조방법 및 그 제조방법으로 제조된 영양제 조성물의 물성을 실시예를 들어 설명하기로 한다.Hereinafter, the method for producing a lactic acid bacterial nutritional composition for companion animals with excellent preference according to the present invention and the physical properties of the nutritional composition prepared by the manufacturing method will be described by way of examples.
<제조예 1> 유산균 혼합물의 제조<Preparation Example 1> Preparation of lactic acid bacteria mixture
락토코커스 락티스(Lactococcus lactis), 락토바실러스 플란타룸(Lactobacillus plantarum), 스트렙토코쿠스 써모필루스(Streptococcus thermophilus), 락토바실러스 아시도필루스(Lactobacillus acidophilus), 비피도박터리움 비피덤(Bifidobacterium bifidum), 락토바실러스 람노서스(Lactobacillus rhamnosus), 락토바실러스 루테리(Lactobacillus reuteri), 비피도박터리움 롱검(Bifidobacterium longum), 락토바실러스 헬베티쿠스(Lactobacillus helveticus), 락토바실러스 파라카제이(Lactobacillus paracasei), 비피도박터리움 아니말리스 ssp. 락티스(Bifidobacterium animalis ssp. lactis), 비피도박터리움 브레베(Bifidobacterium breve), 락토바실러스 살리바리스(Lactobacillus salivarius), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus), 락토바실러스 카제이(Lactobacillus casei), 락토바실러스 가쎄리(Lactobacillus gasseri) 및 락토바실러스 퍼멘툼(Lactobacillus fermentum)을 동일한 중량부로 혼합하여 유산균 혼합물을 제조하였다.Lactococcus lactis , Lactobacillus plantarum, Streptococcus thermophilus, Lactobacillus acidophilus , Bifidobacterium bifidum ), Lactobacillus rhamnosus , Lactobacillus reuteri , Bifidobacterium longum , Lactobacillus helveticus, Lactobacillus paracasei , Bifi Gamutrium animalis ssp. Lactis ( Bifidobacterium animalis ssp. lactis ), Bifidobacterium breve , Lactobacillus salivarius, Lactobacillus bulgaricus , Lactobacillus casei , Lactobacillus A lactic acid bacteria mixture was prepared by mixing Lactobacillus gasseri and Lactobacillus fermentum in equal parts by weight.
<제조예 2> 곡물발효 효소의 제조<Preparation Example 2> Preparation of grain fermentation enzyme
상기 곡물은 현미, 현미율무, 보리, 대두, 흑미, 수수, 옥수수, 통밀, 율무씨앗, 기장씨앗, 검정콩, 차조, 팥, 서목태, 메밀 및 아마란스가 동일한 중량부로 혼합되어 이루어진 곡물 100 중량부에 황국균 0.2 중량부를 접종한 후에 35℃의 온도에서 22시간 동안 발효하여 곡물발효 효소를 제조하였다.The grains are brown rice, brown rice coix, barley, soybeans, black rice, sorghum, corn, whole wheat, coix seeds, millet seeds, black beans, perilla, red beans, black soybeans, buckwheat and amaranth mixed in equal parts by weight, and 100 parts by weight of Hwanggukgyun. After inoculating 0.2 parts by weight, grain fermentation enzyme was prepared by fermenting at a temperature of 35°C for 22 hours.
<제조예 3> 베리류 혼합물의 제조<Preparation Example 3> Preparation of berry mixture
블루베리 분말 및 크랜베리 분말을 1:1의 중량부로 혼합하여 베리류 혼합물을 제조하였다.A berry mixture was prepared by mixing blueberry powder and cranberry powder in a 1:1 weight ratio.
<실시예 1><Example 1>
당성분(무수결정포도당) 66.5g, 상기 제조예 1을 통해 제조된 유산균 혼합물 0.5g, 산화아연 0.4g, 비타민 혼합물(비타민 B1 100 중량부 및 비타민 B6 80 중량부) 0.019g, 프로폴리스 0.15g, 상기 제조예 2을 통해 제조된 곡물발효 효소 0.375g, 오메가-3 0.125g, 치커리 추출물 0.5g, 오르니틴염삼염 0.125g, 고구마 분말 1g, 당근 분말 1g, 보로콜리 분말 1g, 베리류 혼합물 2g, 혈당상승 억제제(난소화성 말토덱스트린) 6.3g, 치즈 분말 3g 및 고결방지제(결정셀룰로오스) 17.007g을 교반기가 구비된 혼합장치에 투입하고 150rpm의 속도로 10분 동안 혼합하여 기호도가 우수한 반려동물용 유산균 영양제 조성물을 제조하였다.66.5 g of sugar component (anhydrous crystalline glucose), 0.5 g of lactic acid bacteria mixture prepared through Preparation Example 1 above, 0.4 g of zinc oxide, 0.019 g of vitamin mixture (100 parts by weight of vitamin B 1 and 80 parts by weight of vitamin B 6 ), propolis 0.15g, 0.375g grain fermentation enzyme prepared through Preparation Example 2, 0.125g omega-3, 0.5g chicory extract, 0.125g ornithine trisalt, 1g sweet potato powder, 1g carrot powder, 1g boroccoli powder, 2g berry mixture , 6.3g of blood sugar rise inhibitor (indigestible maltodextrin), 3g of cheese powder, and 17.007g of anti-caking agent (crystalline cellulose) were added to a mixing device equipped with a stirrer and mixed for 10 minutes at a speed of 150rpm to create a highly palatable pet product. A lactic acid bacteria nutritional composition was prepared.
<실시예 2><Example 2>
상기 실시예 1과 동일하게 진행하되, 당성분(무수결정포도당 60g, 이소말트 5g 및 갈락토 올리고당 1.5g이 혼합)을 사용하여 기호도가 우수한 반려동물용 유산균 영양제 조성물을 제조하였다.A lactic acid bacteria nutritional composition for companion animals with excellent palatability was prepared in the same manner as in Example 1, but using sugar ingredients (60 g of anhydrous crystalline glucose, 5 g of isomalt, and 1.5 g of galacto-oligosaccharide mixed).
<비교예 1><Comparative Example 1>
상기 실시예 1과 동일하게 진행하되, 고결방지제를 사용하지 않고 반려동물용 유산균 영양제 조성물을 제조하였다.A lactic acid bacteria nutritional composition for companion animals was prepared in the same manner as in Example 1, but without using an anti-caking agent.
<비교예 2><Comparative Example 2>
상기 실시예 1과 동일하게 진행하되, 고결방지제 5g을 사용하여 반려동물용 유산균 영양제 조성물을 제조하였다.A lactic acid bacteria nutritional composition for companion animals was prepared in the same manner as in Example 1, but using 5 g of an anti-caking agent.
<비교예 3><Comparative Example 3>
상기 실시예 1과 동일하게 진행하되, 고결방지제 30g을 사용하여 반려동물용 유산균 영양제 조성물을 제조하였다.A lactic acid bacteria nutritional composition for companion animals was prepared in the same manner as in Example 1, but using 30 g of an anti-caking agent.
상기 실시예 1 내지 2 및 비교예 1 내지 3을 통해 제조된 반려동물용 유산균 영양제 조성물의 기호도를 측정하여 아래 표 1에 나타내었다.The preference of the lactic acid bacteria nutritional composition for companion animals prepared through Examples 1 to 2 and Comparative Examples 1 to 3 was measured and shown in Table 1 below.
{단, 기호도는 견사육 시험장에서 급이기가 2개인 케이지에 개를 한 마리씩 배치하고, 매일 오전 10시부터 11시까지 1시간 동안 영양제 조성물을 급여한 후에 용기에 남아있는 영양제의 잔량을 확인하여 평균값으로 나타내는 방법을 이용하였다. 이때, 상기 개는 체중이 3kg 내외인 소형견 5두를 사용하였다.}{However, preference is determined by placing each dog in a cage with two feeders at a dog breeding test site, feeding the nutritional composition for 1 hour from 10 a.m. to 11 a.m. every day, and then checking the amount of nutritional supplement remaining in the container. The method of expressing the average value was used. At this time, five small dogs weighing about 3 kg were used.}
<표 1><Table 1>
상기 표 1에 나타낸 것처럼, 본 발명의 실시예 1 내지 2를 통해 제조된 영양제 조성물은 우수한 기호도를 나타내는 것을 알 수 있으며, 특히, 당성분으로 이소말트와 갈락토 올리고당이 더 함유된 실시예 2를 통해 제조된 영양제 조성물의 기호도가 더욱 우수한 것을 알 수 있다.As shown in Table 1, it can be seen that the nutritional compositions prepared through Examples 1 and 2 of the present invention exhibit excellent preference, and in particular, Example 2, which further contains isomalt and galacto-oligosaccharides as sugar components. It can be seen that the preference of the nutritional composition prepared through this method is superior.
또한, 상기 실시예 1 내지 2 및 비교예 1 내지 3을 통해 제조된 반려동물용 유산균 영양제 조성물의 보존성을 측정하여 아래 표 2에 나타내었다.In addition, the preservability of the lactic acid bacteria nutritional composition for companion animals prepared through Examples 1 to 2 and Comparative Examples 1 to 3 was measured and shown in Table 2 below.
{단, 보존성은 실시예 1 내지 2 및 비교예 1 내지 3을 통해 제조된 반려동물용 유산균 영양제 조성물을 20℃의 온도와 상대습도 50%의 조건에서 72시간 동안 방치하여 고결여부를 육안과 지촉(指觸)으로 확인하는 방법을 이용하였다.{However, preservability is determined by visually observing and checking for solidification by leaving the lactic acid bacterial nutritional composition for pets prepared through Examples 1 to 2 and Comparative Examples 1 to 3 for 72 hours at a temperature of 20°C and 50% relative humidity. A method of confirmation was used.
○:완전 고결, △:부분 고결, ×:고결 없음}○: Completely consolidated, △: Partially consolidated, ×: No consolidation}
<표 2><Table 2>
상기 표 2에 나타낸 것처럼, 본 발명의 실시예 1 내지 2를 통해 제조된 영양제 조성물은 우수한 보존성을 나타내는 것을 알 수 있다.As shown in Table 2, it can be seen that the nutritional compositions prepared through Examples 1 and 2 of the present invention exhibit excellent preservability.
반면, 비교예 1 내지 2를 통해 제조된 영양제 조성물은 고결방지제가 함유되지 않거나 미량 함유되어 보존성이 낮은 것을 알 수 있다.On the other hand, it can be seen that the nutritional compositions prepared through Comparative Examples 1 and 2 do not contain anti-caking agents or contain trace amounts of anti-caking agents, resulting in low preservability.
즉, 본 발명의 실시예 1 내지 2를 통해 제조된 영양제 조성물은 우수한 기호도와 보존성을 나타내지만, 비교예 1 내지 2는 보존성이 낮고 비교예 3은 기호도가 낮은 것을 알 수 있다.That is, it can be seen that the nutritional compositions prepared through Examples 1 and 2 of the present invention exhibit excellent preference and preservability, but Comparative Examples 1 and 2 have low preservability and Comparative Example 3 has low preference.
따라서, 본 발명에 따른 기호도가 우수한 반려동물용 유산균 영양제 조성물은 반려동물의 장에 유익한 성분으로 이루어져 장건강, 모질 및 변비를 개선하며, 우수한 기호도와 보존성을 나타내는 영양제 조성물을 제공한다.Therefore, the lactic acid bacterial nutritional composition for companion animals with excellent palatability according to the present invention consists of ingredients beneficial to the intestines of companion animals, improves intestinal health, coat quality, and constipation, and provides a nutritional composition that exhibits excellent palatability and preservability.
Claims (11)
상기 유산균 혼합물은 락토코커스 락티스(Lactococcus lactis), 락토바실러스 플란타룸(Lactobacillus plantarum), 스트렙토코쿠스 써모필루스(Streptococcus thermophilus), 락토바실러스 아시도필루스(Lactobacillus acidophilus), 비피도박터리움 비피덤(Bifidobacterium bifidum), 락토바실러스 람노서스(Lactobacillus rhamnosus), 락토바실러스 루테리(Lactobacillus reuteri), 비피도박터리움 롱검(Bifidobacterium longum), 락토바실러스 헬베티쿠스(Lactobacillus helveticus), 락토바실러스 파라카제이(Lactobacillus paracasei), 비피도박터리움 아니말리스 ssp. 락티스(Bifidobacterium animalis ssp. lactis), 비피도박터리움 브레베(Bifidobacterium breve), 락토바실러스 살리바리스(Lactobacillus salivarius), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus), 락토바실러스 카제이(Lactobacillus casei), 락토바실러스 가쎄리(Lactobacillus gasseri) 및 락토바실러스 퍼멘툼(Lactobacillus fermentum)으로 이루어지고,
상기 곡물발효 효소는 곡물 100 중량부에 황국균 0.1 내지 0.3 중량부를 접종한 후에 30 내지 40℃의 온도에서 20 내지 25시간 동안 발효하여 제조되며,
상기 곡물은 흑미, 수수, 옥수수, 통밀, 기장씨앗, 검정콩, 차조, 팥, 서목태 및 아마란스로 이루어진 그룹에서 선택된 하나 이상으로 이루어지고,
상기 베리류 혼합물은 크랜베리, 라즈베리, 아로니아, 오디 및 복분자로 이루어진 그룹에서 선택된 하나 이상의 분말로 이루어지며,
상기 변비개선용 조성물은 생지황, 사삼, 지각, 우슬 및 당귀로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것을 특징으로 하는 기호도가 우수한 반려동물용 유산균 영양제 조성물.
100 parts by weight of sugar component, 0.5 to 1 part by weight of lactic acid bacteria mixture, 0.5 to 0.7 parts by weight of zinc oxide, 0.02 to 0.04 parts by weight of vitamin mixture, 0.2 to 0.3 parts by weight of propolis, 0.5 to 0.6 parts by weight of grain fermentation enzyme, omega-3 0.1 to 0.3 parts by weight, chicory extract 0.5 to 1 part by weight, ornithine hydrochloride 0.1 to 0.3 parts by weight, sweet potato powder 1 to 2 parts by weight, carrot powder 1 to 2 parts by weight, broccoli powder 1 to 2 parts by weight, berry mixture 2 It consists of 4 to 4 parts by weight, 8 to 12 parts by weight of a blood sugar level inhibitor, 4 to 5 parts by weight of cheese powder, 20 to 30 parts by weight of an anti-caking agent, and 0.1 to 0.5 parts by weight of a composition for improving constipation,
The lactic acid bacteria mixture includes Lactococcus lactis, Lactobacillus plantarum , Streptococcus thermophilus , Lactobacillus acidophilus , and Bifidobacterium bifi. Bifidobacterium bifidum , Lactobacillus rhamnosus, Lactobacillus reuteri , Bifidobacterium longum , Lactobacillus helveticus, Lactobacillus paracasei paracasei ), Bifidobacterium animalis ssp. Lactis ( Bifidobacterium animalis ssp. lactis ), Bifidobacterium breve , Lactobacillus salivarius, Lactobacillus bulgaricus , Lactobacillus casei , Lactobacillus Consists of Lactobacillus gasseri and Lactobacillus fermentum ,
The grain fermentation enzyme is manufactured by inoculating 0.1 to 0.3 parts by weight of Chrysanthemum fungus into 100 parts by weight of grain and then fermenting for 20 to 25 hours at a temperature of 30 to 40 ° C.
The grain is composed of one or more selected from the group consisting of black rice, sorghum, corn, whole wheat, millet seeds, black beans, perilla, red beans, soybeans, and amaranth,
The berry mixture consists of one or more powders selected from the group consisting of cranberries, raspberries, aronia, mulberries, and bokbunja,
The composition for improving constipation is a lactic acid bacterial nutritional composition for companion animals with excellent palatability, characterized in that it is made of one or more selected from the group consisting of raw rehmannia root, ginseng, crustacean, coriander root, and angelica root.
상기 당성분은 무수결정포도당, 프락토올리고당, 이소말트, 갈락토올리고당, 말토올리고당, 자일로올리고당 및 겐티오올리고당으로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것을 특징으로 하는 기호도가 우수한 반려동물용 유산균 영양제 조성물.
In claim 1,
The sugar component is a lactobacillus nutritional supplement for pets with excellent palatability, characterized in that it consists of one or more selected from the group consisting of anhydrous crystalline glucose, fructooligosaccharide, isomalt, galactooligosaccharide, maltooligosaccharide, xylooligosaccharide, and gentio-oligosaccharide. Composition.
상기 비타민 혼합물은 비타민 B1 및 비타민 B6로 이루어지는 것을 특징으로 하는 기호도가 우수한 반려동물용 유산균 영양제 조성물.
In claim 1,
The vitamin mixture is a lactic acid bacterial nutritional composition for pets with excellent palatability, characterized in that it consists of vitamin B 1 and vitamin B 6 .
상기 혈당상승 억제제는 난소화성말토덱스트린으로 이루어지는 것을 특징으로 하는 기호도가 우수한 반려동물용 유산균 영양제 조성물.
In claim 1,
A lactic acid bacterial nutritional composition for companion animals with excellent palatability, characterized in that the blood sugar rise inhibitor consists of indigestible maltodextrin.
상기 고결방지제는 결정 셀룰로오스로 이루어지는 것을 특징으로 하는 기호도가 우수한 반려동물용 유산균 영양제 조성물.
In claim 1,
A lactic acid bacterial nutritional composition for companion animals with excellent palatability, characterized in that the anti-caking agent is made of crystalline cellulose.
상기 기호도가 우수한 반려동물용 유산균 영양제 조성물에는 상기 당성분 100 중량부 대비 천연보존제 0.01 내지 0.1 중량부가 더 함유되며,
상기 천연보존제는 녹차, 머스타드, 로즈마리 및 세이지로 이루어진 그룹에서 선택된 하나의 동결건조 분말인 것을 특징으로 하는 기호도가 우수한 반려동물용 유산균 영양제 조성물.
In claim 1,
The lactic acid bacteria nutritional composition for pets with excellent preference contains 0.01 to 0.1 parts by weight of natural preservative relative to 100 parts by weight of the sugar component,
A lactobacillus nutritional composition for pets with excellent palatability, wherein the natural preservative is a freeze-dried powder selected from the group consisting of green tea, mustard, rosemary, and sage.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020230051597A KR102625196B1 (en) | 2023-04-19 | 2023-04-19 | Lactic acid bacteria nutritional composition for companion animals with excellent palatability |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020230051597A KR102625196B1 (en) | 2023-04-19 | 2023-04-19 | Lactic acid bacteria nutritional composition for companion animals with excellent palatability |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR102625196B1 true KR102625196B1 (en) | 2024-01-15 |
Family
ID=89542826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020230051597A KR102625196B1 (en) | 2023-04-19 | 2023-04-19 | Lactic acid bacteria nutritional composition for companion animals with excellent palatability |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR102625196B1 (en) |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030000822A (en) | 2001-06-27 | 2003-01-06 | 주식회사 하이닉스반도체 | method for fabricating of semiconductor device |
| US20030190309A1 (en) * | 2000-05-25 | 2003-10-09 | Ralf Zink | Novel probiotics for pet food applications |
| US20140242215A1 (en) * | 2011-10-03 | 2014-08-28 | Specialites Pet Food | Animal digests having enhanced palatability for use in pet food |
| KR101919759B1 (en) * | 2018-07-31 | 2018-11-19 | 이대훈 | Composition for preventing or improving bone-related disease comprising polysaccharide purified from seaweed extract as effective component |
| KR20210047789A (en) * | 2019-12-30 | 2021-04-30 | 박다올 | Nutritional snack composition for pets |
| KR102270024B1 (en) | 2019-07-19 | 2021-06-30 | 유한회사 비피코리아 | Solid lactic acid bacteria for companion animal and manufacturing method thereof |
| KR102420269B1 (en) * | 2022-03-18 | 2022-07-13 | 박종호 | Health functional food composition for improvement of skin health of companion animals |
| KR102420268B1 (en) * | 2022-03-17 | 2022-07-13 | 박종호 | Nutritional composition for improving eye health for companion animals |
| KR102437362B1 (en) * | 2022-03-17 | 2022-08-29 | 박종호 | Nutritional composition for improving articulation health for companion animals |
| KR102514295B1 (en) * | 2022-11-02 | 2023-03-28 | 이대훈 | Nutritional supplements for patella strengthening of companion animals and manufacturing method thereof |
| KR20230044632A (en) * | 2021-09-27 | 2023-04-04 | 주식회사 루씨베이전씨 | Health function food composition comprising lactobacillus for improving skin and vowel function and method of preparing the same |
-
2023
- 2023-04-19 KR KR1020230051597A patent/KR102625196B1/en active IP Right Grant
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030190309A1 (en) * | 2000-05-25 | 2003-10-09 | Ralf Zink | Novel probiotics for pet food applications |
| KR20030000822A (en) | 2001-06-27 | 2003-01-06 | 주식회사 하이닉스반도체 | method for fabricating of semiconductor device |
| US20140242215A1 (en) * | 2011-10-03 | 2014-08-28 | Specialites Pet Food | Animal digests having enhanced palatability for use in pet food |
| KR101919759B1 (en) * | 2018-07-31 | 2018-11-19 | 이대훈 | Composition for preventing or improving bone-related disease comprising polysaccharide purified from seaweed extract as effective component |
| KR102270024B1 (en) | 2019-07-19 | 2021-06-30 | 유한회사 비피코리아 | Solid lactic acid bacteria for companion animal and manufacturing method thereof |
| KR20210047789A (en) * | 2019-12-30 | 2021-04-30 | 박다올 | Nutritional snack composition for pets |
| KR20230044632A (en) * | 2021-09-27 | 2023-04-04 | 주식회사 루씨베이전씨 | Health function food composition comprising lactobacillus for improving skin and vowel function and method of preparing the same |
| KR102420268B1 (en) * | 2022-03-17 | 2022-07-13 | 박종호 | Nutritional composition for improving eye health for companion animals |
| KR102437362B1 (en) * | 2022-03-17 | 2022-08-29 | 박종호 | Nutritional composition for improving articulation health for companion animals |
| KR102420269B1 (en) * | 2022-03-18 | 2022-07-13 | 박종호 | Health functional food composition for improvement of skin health of companion animals |
| KR102514295B1 (en) * | 2022-11-02 | 2023-03-28 | 이대훈 | Nutritional supplements for patella strengthening of companion animals and manufacturing method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2394062T3 (en) | Animal feed croquette with a protein-based core and related methods | |
| CN104522433B (en) | A kind of laying hen composite biological feed additive and preparation method thereof | |
| JP2008535521A (en) | Pet food composition comprising two ingredients | |
| CN105410365B (en) | A kind of feed addictive of alternative antibiotic and its application | |
| CN108244252A (en) | Probiotics multielement protein powder and preparation method thereof | |
| CN103271274B (en) | Nutrient health-care porridge | |
| CN107259164A (en) | A kind of special grain of pet cat and preparation method thereof | |
| US11141442B2 (en) | Tributyrin compositions and methods therefor | |
| CN109907159A (en) | A kind of animal feed additive and its application | |
| CN1969941A (en) | Fox immunity enhancer | |
| JP2021512855A (en) | Health-beneficial compositions containing lactobacillus and methods for preparing them | |
| CN109673861A (en) | A kind of cat algal fungi nutrient laden hair cream and preparation method thereof | |
| CN106689753A (en) | Weaned piglet feed compound preparation, feed containing the compound preparation and application of the feed | |
| ES2357408T3 (en) | SYMBOLIC COMPOSITION AND ITS MANUFACTURING PROCEDURE. | |
| CN101297679A (en) | Feedstuff additive for improving immunity of livestock and poultry and preparation thereof | |
| CN104522423A (en) | 45% small conservation concentrate and preparation method thereof | |
| US20210177028A1 (en) | Improved human food product | |
| KR102625196B1 (en) | Lactic acid bacteria nutritional composition for companion animals with excellent palatability | |
| CN108850613A (en) | Fattening pannage and preparation method thereof | |
| KR102182093B1 (en) | Oral composition comprising graviola mixed powder easy to take | |
| CN107183349A (en) | A kind of child care pig high protein mulberry mixed feed | |
| CN105284735A (en) | Method for feeding drug residue-free Wenshang Luhua cock at age of 6-18 weeks | |
| CN106889615A (en) | A kind of trace elements of selenium dietary supplements and its application with regulating intestinal canal flora function | |
| KR102625195B1 (en) | Nutrient composition for improving bronchial health of companion animals | |
| CN108850592A (en) | A kind of three way cross fattening later period pig feed additive for promoting growth and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant |